[Edaily Starin YUN GI BACK Reporter] The group &TEAM is set to take the stage at the Grammy Museum in the U.S., further expanding its global reach. By broadening its connection with the U.S. music market beyond Asia, the group appears to be strengthening its presence as “HYBE’s first global group.” (Photo courtesy of YX Labels) According to their agency, YX Labels, on the 17th, &TEAM will appear at “Global Spin Live,” taking place on August 12 (local time) at the Grammy Museum in Los Angeles, USA. “Global Spin Live” is a flagship program hosted by the Grammy Museum that invites notable artists from around the world to present performances and talks. On the day of the event, ANTEAM will not only showcase a performance on stage but also discuss their music, activities, and future plans with host Emily Mei. The Grammy Museum has also taken notice of ANTEAM. Through its official social media channels, the museum introduced the group, stating, “ANTEAM is a group born from the vision of nine individuals with distinct personalities coming together as one team to connect diverse worlds,” adding, “They are a group ready to captivate audiences worldwide with their unique energy and passion.” This appearance is a symbolic step demonstrating ANTEAM’s global expansion. Having started their activities in Japan, ANTEAM has expanded their fanbase primarily in Korea and Asia, and is currently on an Asian tour visiting 14 cities. With the addition of their performance at the Grammy Museum, they are set to significantly broaden their reach among American music fans. N.Team will release their second Korean mini-album, *Mark on Me*, on September 8 and continue their promotional activities both domestically and internationally.
The way global private equity fund (PEF) managers invest in rental housing is evolving. Previously, most cases involved directly purchasing individual properties. However, transactions have recently e…
SK hynix has drawn a clear line regarding reports that it is pursuing the sale of its stake in its Chongqing, China, plant, stating, “Nothing has been finalized.” This is the company’s response to a r…
Medy-Tox Inc.(086900)Medytox continued its revenue growth in the second quarter of this year, driven by expanded overseas sales of botulinum toxin and dermal fillers, as well as the successful market …